Artificial Intelligence (AI) offers various opportunities in medical research, but the use of patient data frequently raises privacy concerns. In a recent position paper, Dr. Carsten Marr, a scientist at Helmholtz Munich, and other authors address…
A new study found that hypertension patients who took their blood pressure medication at a time aligned with their body clock had a reduced risk of heart attack.
This year, the highest award of the German Diabetes Association (DDG) – the Paul Langerhans Medal – is awarded to Prof. Dr. med. Anette-Gabriele Ziegler. The Director of the Institute of Diabetes Research at Helmholtz Munich and scientist at the…
A team led by Helmholtz Munich scientist Dr. Grzegorz Popowicz unveils the Molecular Interactions Structurally Optimized (MISATO) dataset, offering a transformative approach to training AI models for designing new drug molecules. MISATO represents a…
The German Radiological Society has awarded the Alfred Breit Prize this year to Prof. Julia Schnabel, Director at the Institute of Machine Learning in Biomedical Imaging at Helmholtz Munich and Professor at the Technical University of Munich. The…
Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) collaborates within a European network to develop new…
Awards & Grants, IDF,
Awards & Grants, IML,
Awards & Grants, Environmental Health, COMI,
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: